Skip to main content
OpenTrials
Completed

NCT Number: NCT06533306

Metachronous Acquired Contralateral Cryptorchidism in Patients With a History of Unilateral Cryptorchidism.

The present study aims to calculate the risk of a patient with a history of cryptorchidism developing cryptorchidism on the contralateral side.

Completed

Looking for future studies?

Notify Me

Key information

Age range

13 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Consorci Sanitari Alt Penedès-Garraf

Vilafranca del Penedès, Barcelona, 08720, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 13 years or older, previously operated on for cryptorchidism.

Exclusion criteria

  • Diagnosis of endocrine disease or any polymalformative syndrome.
  • Synchronous bilateral cryptorchidism.

Treatment and study plan

Surgery for cryptorchidism.

Procedure

Patients previously operated on for cryptorchidism.

Primary outcomes

  1. Contralateral Cryptorchidism

    Time frame: Up to 1 month

    Proportion of patients previously operated on for cryptorchidism in whom acquired contralateral cryptorchidism is detected.

Sponsors and collaborators

Lead sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Other

Registry information

Official study title

Estimation of the Risk of Presenting Metachronous Acquired Contralateral Cryptorchidism in Patients With a History of Unilateral Cryptorchidism.

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Aug 1, 2024
Registry last updated
Aug 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.